JPWO2019243169A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019243169A5 JPWO2019243169A5 JP2021520455A JP2021520455A JPWO2019243169A5 JP WO2019243169 A5 JPWO2019243169 A5 JP WO2019243169A5 JP 2021520455 A JP2021520455 A JP 2021520455A JP 2021520455 A JP2021520455 A JP 2021520455A JP WO2019243169 A5 JPWO2019243169 A5 JP WO2019243169A5
- Authority
- JP
- Japan
- Prior art keywords
- lactobacillus plantarum
- pharmaceutical composition
- probiotic strain
- dietary supplement
- cfu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2018/066154 WO2019242839A1 (en) | 2018-06-18 | 2018-06-18 | Lactobacillus plantarum compositions and uses thereof |
| EPPCT/EP2018/066154 | 2018-06-18 | ||
| PCT/EP2019/065590 WO2019243169A1 (en) | 2018-06-18 | 2019-06-13 | Lactobacillus plantarum compositions and uses thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021527718A JP2021527718A (ja) | 2021-10-14 |
| JPWO2019243169A5 true JPWO2019243169A5 (https=) | 2022-05-17 |
| JP2021527718A5 JP2021527718A5 (https=) | 2022-05-17 |
| JP7476183B2 JP7476183B2 (ja) | 2024-04-30 |
Family
ID=62842054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021520455A Active JP7476183B2 (ja) | 2018-06-18 | 2019-06-13 | ラクトバチルス・プランタルムの組成物およびその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12558385B2 (https=) |
| EP (1) | EP3806876B1 (https=) |
| JP (1) | JP7476183B2 (https=) |
| KR (1) | KR102770563B1 (https=) |
| CN (1) | CN112638393B (https=) |
| AU (1) | AU2018428571B2 (https=) |
| BR (1) | BR112020026076A2 (https=) |
| CA (1) | CA3102445A1 (https=) |
| ES (1) | ES2966935T3 (https=) |
| MX (1) | MX2020013860A (https=) |
| PL (1) | PL3806876T3 (https=) |
| WO (2) | WO2019242839A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3102445A1 (en) | 2018-06-18 | 2019-12-26 | Probi Ab | Lactobacillus plantarum compositions and uses thereof |
| GB201908154D0 (en) * | 2019-06-07 | 2019-07-24 | Probi Ab | Lactobacillus compositions and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1429802T3 (da) | 2001-09-28 | 2013-02-18 | Tntgamble Inc | Tilførselssystem for biologisk komponent |
| US20070098784A1 (en) | 2001-09-28 | 2007-05-03 | Nutraceutix, Inc. | Delivery system for biological component |
| SE527555C2 (sv) | 2003-04-04 | 2006-04-11 | Probi Ab | Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar |
| ZA200802934B (en) * | 2005-10-06 | 2009-09-30 | Probi Ab | Use of lactobacillus for treatment of virus infections |
| AU2006297896B2 (en) * | 2005-10-06 | 2011-12-08 | Probi Ab | Use of lactobacillus for treatment of autoimmune diseases |
| SE532899C2 (sv) * | 2007-06-08 | 2010-05-04 | Probi Ab | Förfarande genom fermentering med Lactobacillus plantarum för tillhandahållande av en insulinsvarsreducerande produkt och dess användning farmaceutiskt eller i livsmedel |
| SE533778C2 (sv) | 2009-05-14 | 2011-01-11 | Probi Ab | Probiotisk fruktdryck |
| US10245290B2 (en) | 2013-04-03 | 2019-04-02 | Probi Ab | Probiotic strains for use in treatment or prevention of osteoporosis |
| MX383492B (es) | 2014-07-01 | 2025-03-04 | Probi Usa Inc | Comprimidos probióticos bicapa de doble liberación. |
| US20180289052A1 (en) | 2015-10-07 | 2018-10-11 | Bifodan A/S | Probiotic formulation |
| GB201600975D0 (en) | 2016-01-19 | 2016-03-02 | Probi Ab | Novel strain of probiotic bacteria and compositions and uses thereof |
| GB201708932D0 (en) | 2017-06-05 | 2017-07-19 | Probi Ab | Microbial compositions |
| CA3102445A1 (en) | 2018-06-18 | 2019-12-26 | Probi Ab | Lactobacillus plantarum compositions and uses thereof |
-
2018
- 2018-06-18 CA CA3102445A patent/CA3102445A1/en active Pending
- 2018-06-18 AU AU2018428571A patent/AU2018428571B2/en active Active
- 2018-06-18 KR KR1020217000189A patent/KR102770563B1/ko active Active
- 2018-06-18 WO PCT/EP2018/066154 patent/WO2019242839A1/en not_active Ceased
-
2019
- 2019-06-13 WO PCT/EP2019/065590 patent/WO2019243169A1/en not_active Ceased
- 2019-06-13 JP JP2021520455A patent/JP7476183B2/ja active Active
- 2019-06-13 CN CN201980040689.1A patent/CN112638393B/zh active Active
- 2019-06-13 PL PL19733414.7T patent/PL3806876T3/pl unknown
- 2019-06-13 ES ES19733414T patent/ES2966935T3/es active Active
- 2019-06-13 MX MX2020013860A patent/MX2020013860A/es unknown
- 2019-06-13 US US17/252,854 patent/US12558385B2/en active Active
- 2019-06-13 EP EP19733414.7A patent/EP3806876B1/en active Active
- 2019-06-13 BR BR112020026076-2A patent/BR112020026076A2/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7528153B2 (ja) | 抑うつ症状を治療又は予防するための、ビフィドバクテリウム・ロンガムを用いる、方法及び組成物 | |
| US10501530B2 (en) | Probiotics, secretory IgA and inflammation | |
| JP6651450B2 (ja) | 酪酸、葉酸、又はナイアシンの腸内産生を増加させるための、及び／又はコハク酸の腸内産生を低下させるための、微生物を含む組成物の使用 | |
| Sharma et al. | RETRACTED: Probiotics: A Comprehensive Approach toward Health Foods | |
| JP6444358B2 (ja) | ペディオコッカスを含有する医薬組成物および消化器症候群の症状を低減する方法 | |
| JP7523493B2 (ja) | 情動的反応を制御するため、並びに潜在的な気分変調の治療及び予防のための、ビフィドバクテリウム・ロンガムを用いる、方法及び組成物 | |
| JP5400997B2 (ja) | 哺乳動物の大腸内のガス発生及びこれに起因する腹部症状を回避又は低減するための、鉱物質及び場合によっては酢酸生成菌及び／又は酪酸生成菌からなる組成物の使用 | |
| EP2308498A1 (en) | Administration of Bifidobacterium breve during infancy to prevent inflammation later in life | |
| JP6484561B2 (ja) | Ｌａｃｔｏｂａｃｉｌｌｕｓｆｅｒｍｅｎｔｕｍ（ラクトバチルス・ファーメンタム）ｍｅ−３を用いる治療方法 | |
| JP7366540B2 (ja) | メタボリックシンドローム治療用栄養補助食品および食品組成物 | |
| JP6050341B2 (ja) | 改善された食品組成物 | |
| JP2021527718A5 (https=) | ||
| EP4176890A1 (en) | Oxytocin-mimetic compositions and uses thereof | |
| JPWO2019243169A5 (https=) | ||
| Asp et al. | Probiotics in gastric and intestinal disorders as functional food and medicine | |
| US20250352589A1 (en) | Oxytocin-mimetic compositions and uses thereof | |
| JP4787159B2 (ja) | 抗ストレス剤 | |
| US11020440B2 (en) | Probiotic for the treatment of psoriasis | |
| CN121081512A (zh) | 一种益生菌组合物在制备缓解疼痛的产品中的应用 | |
| Myllyluoma et al. | Functional dairy products for gastrointestinal infections and dysfunction | |
| TW202417026A (zh) | 益生菌組合及其用於腸胃道保健或提升免疫力的用途 | |
| Valmar | AnMar Pharma | |
| KOTWAL | PROBIOTICS AND INFECTIOUS AGENTS BHARAT MENGI1, SK KOTWAL1 AND MANINDER SINGH1 | |
| Calafiore et al. | Gastroenterology and Hepatology Research | |
| HK1140430A (en) | Product containing inactivated probiotic for children or infants |